Braidwell »

Exact Sciences Corp note 0.375% 3/0 shares owned by Braidwell

Quarter-by-quarter ownership of Exact Sciences Corp note 0.375% 3/0 shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Exact Sciences Corp note 0.375% 3/0

Tip: Access up to 7 years of quarterly data

All positions including Exact Sciences Corp note 0.375% 3/0 held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Exact Sciences Corp note 0.375% 3/0 by Braidwell

Quarter filed Position value Share count Share price at filing
2023-12-31 $123M 131M 0.94
2023-09-30 $114M 131M 0.87
2023-06-30 $135M 131M 1.03
2023-03-31 $123M 139M 0.88
2022-12-31 $110M 139M 0.79

More positions owned by Braidwell

Guardant Health Note 11/1 (Principal)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)
Exact Sciences Corp Note 0.375% 3/0 (Principal)
Novocure Note 11/0 (Principal)
Neurocrine Biosciences (NBIX)
Vaxcyte (PCVX)
Xenon Pharmaceuticals (XENE)
Nuvasive Note 0.375% 3/1 (Principal)
Insulet Corp Note 0.375% 9/0 (Principal)
Tandem Diabetes Care Note 1.500% 5/0 (Principal)
Day One Biopharmaceuticals I (DAWN)
Irhythm Technologies (IRTC)
Argenx Se Sponsored Adr (ARGX)
Bridgebio Pharma Note 2.250% 2/0 (Principal)

View all positions for Braidwell

Top funds holding Exact Sciences Corp note 0.375% 3/0

Braidwell
Lazard Asset Management
MacKay Shields
Readystate Asset Management
HBK Investments
CNH Partners
SSI Investment Management
M&g Investment Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Bnp Paribas Arbitrage, Snc
New York State Common Retirement Fund
RWC Asset Management
Wells Fargo & Company
Lord, Abbett & Co
Ofi Invest Asset Management

View all funds holding Exact Sciences Corp note 0.375% 3/0